William Gerard Bornmann
Affiliations: | Bayou Therapeutics Inc. |
Area:
anti-cancer drug design and synthesisTotal Synthesis of Natural ProductsGoogle:
"William Bornmann"Mean distance: 8.71 | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lin Y, Satani N, Hammoudi N, et al. (2017) Abstract A39: Pomhex, a cell-permeable high potency enolase inhibitor with utility for collateral lethality treatment of cancer Molecular Cancer Therapeutics. 16 |
| Leonard PG, Satani N, Maxwell D, et al. (2016) SF2312 is a natural phosphonate inhibitor of enolase. Nature Chemical Biology |
| Velez J, Pan R, Lee JT, et al. (2016) Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport. Oncotarget |
| Li LS, Reddy S, Lin ZH, et al. (2016) NQO1-mediated tumor-selective lethality and radiosensitization for head and neck cancer. Molecular Cancer Therapeutics |
| Lin Y, Satani N, Hammoudi N, et al. (2016) POMHEX, a cell-permeable enolase inhibitor for collateral lethality targeting of ENO1-deleted glioblastoma European Journal of Cancer. 69: S124 |
| Caruso JA, Campana R, Wei C, et al. (2014) Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells. Cell Cycle (Georgetown, Tex.). 13: 2587-99 |
| Zhang W, Ruvolo VR, Gao C, et al. (2014) Evaluation of apoptosis induction by concomitant inhibition of MEK, mTOR, and Bcl-2 in human acute myelogenous leukemia cells. Molecular Cancer Therapeutics. 13: 1848-59 |
| Cao L, Li LS, Spruell C, et al. (2014) Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers. Antioxidants & Redox Signaling. 21: 237-50 |
| Peng Z, Maxwell DS, Sun D, et al. (2014) Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I). Bioorganic & Medicinal Chemistry. 22: 1450-8 |
| Pal A, Sung B, Bhanu Prasad BA, et al. (2014) Curcumin glucuronides: Assessing the proliferative activity against human cell lines Bioorganic and Medicinal Chemistry. 22: 435-439 |